Table 3.

Outcome assessments experimental phase B

Study period
	Enrollment			Treatment		Follow-up
Timepoints				0	23 days	1 weeks	2 weeks	3 weeks	6 weeks	8 weeks	10 weeks	3 months	18 weeks	6 months	12 months
IC		X
Preop + serology			X
Physicalexam	X	X				X	X	X	X	X	X	X	X	X	X
VAS		X				X	X	X	X	X	X	X	X	X	X
VISA-P		X				X	X	X	X	X	X	X	X	X	X
blood test												X
BM				X
MSV					X
Bloodbank				X
MRI		X										X*	X	X	X
Ultrasound		X				X	X	X	X	X	X	X	X	X	X
UTC			X					X		X		X	X	X	X
DYN			X					X		X		X	X	X	X
AE				X	X	X	X	X	X	X	X	X	X	X	X
Medication				X	X	X	X	X	X	X	X	X	X	X	X

VAS visual analog scale; VISA-P Victorian Institute of Sport Assessment (Patellar); BM bone marrow harvest; MSV injection of MSV; MRI magnetic resonance imaging; UTC ultrasound tissue characterization; DYN dynamometry, PreOp preoperative study, AE adverse Events.

X* this MRI test will establish the status of the healing process at 3 months.